Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ONCO CONSULTING AS
AS
Active
Org 925572144
Solveien 112D, 1162 Oslo
Medical specialists activities · NACE 8622
Est. 2020
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 1,1M
-15% vs 2023
EBITDA margin
89.5%
-18% vs 2023
Equity ratio
88.4%
Financial strength
Net profit 2024
NOK 693K
-18% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
0M
2020
1M
+100%
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 1,1M
-15%
EBITDA
NOK 1M
-18%
Net profit
NOK 693K
-18%
Total assets
NOK 1,8M
+16%
Equity
NOK 1,6M
+22%
Employees
0
—
Company information
Legal name
ONCO CONSULTING AS
Org number
925572144
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
2. september 2020
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Konsulentvirksomhet.
Contact
Address
Solveien 112D, 1162 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
1M
2021
1M
2022
1M
2023
1M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
1M
2021
1M
2022
1M
2023
1M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
948
1 050
1 357
1 150
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−0
874
924
1 250
1 029
Depreciation & amort.
−0
−243
−216
−173
−138
EBIT
−0
631
707
1 077
891
Net financials
0
−6
−0
−0
−2
Profit before tax
−0
625
707
1 077
889
Tax
−0
136
156
237
196
Net profit
−0
489
552
840
693
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
24
1 350
1 249
1 557
1 808
Equity
24
513
1 065
1 305
1 597
Long-term debt
0
705
4
3
3
Short-term debt
0
132
180
249
208
Total debt
0
836
184
252
210
Financial ratios
5-year trend
EBITDA margin
89.5%
This company
15.8%
Market median
+466% vs market
2020
2024
Equity ratio
88.4%
This company
38.2%
Market median
+131% vs market
2020
2024
Return on equity
43.4%
This company
18.4%
Market median
+136% vs market
2020
2024
Net profit margin
60.2%
This company
8.1%
Market median
+643% vs market
2020
2024
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
2020
2024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-08-21 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
SD
Svein Dueland
Chairman
2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of ONCO CONSULTING AS also hold positions in
0
other companies.
Person
Role here
Other companies
Svein Dueland
Chairman
0 companies